Skip to content

Wave Life Sciences WVE Total Operating Expenses

Total Operating Expenses at other companies

Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$404.06M+86.6%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$138.95M+9.6%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$125.28M+2.4%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$227.59M+10.6%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$41.11M-5.5%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$164.13M+196%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's total operating expenses?
Wave Life Sciences (WVE) reported total operating expenses of $69.54M in Q1 2026.
How has Wave Life Sciences's total operating expenses changed year-over-year?
Wave Life Sciences's total operating expenses increased by 17.9% year-over-year, from $58.98M to $69.54M.
What is the long-term trend for Wave Life Sciences's total operating expenses?
Over 4 years (2021 to 2025), Wave Life Sciences's total operating expenses has grown at a 11.3% compound annual growth rate (CAGR), from $167.98M to $258.11M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.